China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Capital Reinvestment Ratio
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Capital Reinvestment Ratio of 3.33x as of December 2025, meaning it reinvests 3% of its operating cash flow (CN¥36.82 Million) in capital expenditures (CN¥122.46 Million). See free cash flow generation of China Resources Boya Bio pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Resources Boya Bio pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks China Resources Boya Bio pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 15 annual periods.
Annual Capital Reinvestment Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2025. For live market cap and broader valuation context, see China Resources Boya Bio pharmaceutical (300294) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.59x | CN¥116.69 Million | CN¥535.31 Million | ▲ +595.3% |
| 2024 | 0.66x | CN¥299.78 Million | CN¥197.79 Million | ▲ +383.9% |
| 2023 | 0.14x | CN¥641.73 Million | CN¥87.50 Million | ▼ -41.2% |
| 2022 | 0.23x | CN¥596.44 Million | CN¥138.41 Million | ▲ +358.3% |
| 2021 | 0.05x | CN¥1.35 Billion | CN¥68.12 Million | ▼ -74.5% |
| 2020 | 0.20x | CN¥718.58 Million | CN¥142.51 Million | ▼ -93.9% |
| 2018 | 3.26x | CN¥34.90 Million | CN¥113.90 Million | ▲ +116.1% |
| 2016 | 1.51x | CN¥198.76 Million | CN¥300.09 Million | ▲ +39.3% |
| 2015 | 1.08x | CN¥147.02 Million | CN¥159.37 Million | ▲ +175.9% |
| 2014 | 0.39x | CN¥121.88 Million | CN¥47.89 Million | ▲ +6.4% |
| 2013 | 0.37x | CN¥89.11 Million | CN¥32.90 Million | ▲ +39.5% |
| 2012 | 0.26x | CN¥92.36 Million | CN¥24.45 Million | ▲ +18.1% |
| 2011 | 0.22x | CN¥81.53 Million | CN¥18.27 Million | ▼ -84.9% |
| 2010 | 1.48x | CN¥24.77 Million | CN¥36.65 Million | ▲ +38.6% |
| 2009 | 1.07x | CN¥51.88 Million | CN¥55.40 Million | — |